Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;4(4):1016-23.
doi: 10.1016/j.actbio.2008.02.017. Epub 2008 Mar 5.

Immobilization of glycoproteins, such as VEGF, on biodegradable substrates

Affiliations

Immobilization of glycoproteins, such as VEGF, on biodegradable substrates

J L Sharon et al. Acta Biomater. 2008 Jul.

Abstract

Attachment of growth factors to biodegradable polymers, such as poly(lactide-co-glycolide) (PLGA), may enhance and/or accelerate integration of tissue engineering scaffolds. Although proteins are commonly bound via abundant amino groups, a more selective approach may increase bioactivity of immobilized molecules. In this research, exposed carboxyl groups on acid-terminated PLGA were modified with dihydrazide spacer molecules. The number of hydrazide groups available for subsequent attachment of protein was dependent on dihydrazide length, with shorter molecules present at significantly greater surface densities. The potent angiogenic glycoprotein vascular endothelial growth factor (VEGF) was oxidized with periodate and the aldehyde moieties allowed to react with the hydrazide-derivatized PLGA. Derivatization initially affected the amount of protein bound to the surfaces, but differences were substantially reduced following overnight incubation in saline. More importantly, use of shorter dihydrazide spacers significantly enhanced accessibility of immobilized VEGF for binding neutralizing antibody and soluble VEGF receptor. Furthermore, immobilized growth factor enhanced endothelial cell proliferation, with surfaces having the shortest and longest spacers stimulating greater effects. The present work has not only demonstrated an alternative approach to immobilizing growth factors on biodegradable materials, but the scheme can be used to alter the amount of protein bound as well as its availability for subsequent biointeractions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of dihydrazide spacer molecules having increasing length.
Figure 2
Figure 2
Idealized scheme for dihydrazide attachment to PLGA.
Figure 3
Figure 3
Idealized scheme for VEGF attachment to dihydrazide-modified PLGA.
Figure 4
Figure 4
Surface density of hydrazide groups available on PLGA following derivatization with dihydrazide spacers of increasing length.
Figure 5
Figure 5
Amount of VEGF bound to hydrazide-derivatized PLGA and directly on carbodiimide-activated PLGA surfaces initially and following overnight incubation in PBS.
Figure 6
Figure 6
Accessibility of VEGF immobilized on hydrazide-derivatized PLGA and directly on carbodiimide-activated PLGA surfaces. (a) Binding of neutralizing antibody before and after overnight incubation in PBS. (b) Binding of sVEGF R2/Fc chimera following overnight incubation in PBS.
Figure 6
Figure 6
Accessibility of VEGF immobilized on hydrazide-derivatized PLGA and directly on carbodiimide-activated PLGA surfaces. (a) Binding of neutralizing antibody before and after overnight incubation in PBS. (b) Binding of sVEGF R2/Fc chimera following overnight incubation in PBS.
Figure 7
Figure 7
Proliferation of endothelial cells seeded on VEGF bound to hydrazide-derivatized PLGA and directly on carbodiimide-activated PLGA surfaces following overnight incubation in PBS. For comparison, cells were also incubated with 10 ng ml−1 soluble VEGF.

Similar articles

Cited by

References

    1. Caplan AI, Goldberg VM. Principles of tissue engineered regeneration of skeletal tissues. Clin. Orthop. 1999;367:S12–S16. - PubMed
    1. Han K, Choi M, Chung Y. Site-specific degradation and transport of recombinant human epidermal growth factor (rhEGF) in the rat gastrointestinal mucosa. Int. J. Pharm. 1998;168:189–197.
    1. Bastian SE, Walton PE, Belford DA. Transport of circulating IGF-I and LR3IGF-I from blood to extracellular wound fluid sites in rats. J. Endocrinol. 2000;164:77–86. - PubMed
    1. Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM, Galante JO. Enhancement of bone ingrowth by transforming growth factor-β. J. Bone Joint Surg. 1995;77A:1135–1147. - PubMed
    1. Lind M, Overgaard S, Nguyen T, Ongpipattanakul B, Bunger C, Soballe K. Transforming growth factor-β stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. Acta Orthop. Scand. 1996;67:611–616. - PubMed

Publication types

LinkOut - more resources